The potent anti-HIV microbicide griffithsin was expressed to high levels in tobacco chloroplasts, enabling efficient purification from both fresh and dried biomass, thus providing storable material for inexpensive production and scale-up on demand.
The global HIV epidemic continues to grow, with 1.8 million new infections occurring per year. In the absence of a cure and an AIDS vaccine, there is a pressing need to prevent new infections in order to curb the disease. Topical microbicides that block viral entry into human cells can potentially prevent HIV infection. The antiviral lectin griffithsin has been identified as a highly potent inhibitor of HIV entry into human cells. Here we have explored the possibility to use transplastomic plants as an inexpensive production platform for griffithsin. We show that griffithsin accumulates in stably transformed tobacco chloroplasts to up to 5% of the total soluble protein of the plant. Griffithsin can be easily purified from leaf material and shows similarly high virus neutralization activity as griffithsin protein recombinantly expressed in bacteria. We also show that dried tobacco provides a storable source material for griffithsin purification, thus enabling quick scale-up of production on demand.
The global human immunodeficiency virus (HIV) epidemic continues to grow, with more than 36.7 million people now estimated to carry the virus (UNAIDS Report 2017: http://www.unaids.org/en/resources/documents/2017/2017_data_book). Although global scale-up of antiretroviral therapy has recently resulted in a substantial decline in deaths from AIDS-related causes, HIV was still responsible for approximately a million deaths in 2016. At the same time, 1.8 million new infections occur per year, resulting in a continuous net increase in infected individuals (UNAIDS Report 2017: http://www.unaids.org/en/resources/documents/2017/2017_data_book). In the absence of a cure that would eliminate the virus, it is therefore of utmost importance to reduce the number of new infections. Unfortunately, despite enormous efforts to develop immunization strategies against HIV, an AIDS vaccine is currently not in sight (Levine 2008; Virgin and Walker 2010; Haase 2010; Andrabi et al. 2018). Topical (vaginal and rectal) microbicides that potentially prevent new infections, therefore, represent one of the most promising strategies to control the disease (Boyd et al. 1997; Lederman et al. 2004; Mori et al. 2005; Veazey et al. 2005; Rao et al. 2005; Vanpouille et al. 2012; O’Keefe et al. 2015).
Inhibitors that block entry of the virus into human cells are particularly suitable to prevent infection (Lederman et al. 2004; Veazey et al. 2005). Large-scale screens for peptides, proteins and small molecules that act as virus-cell fusion inhibitors have been conducted and a number of candidate molecules have been identified. One of the first potent antiviral agents that was found to bind to the HIV surface and block viral entry into cells was cyanovirin-N (CV-N), a small protein (11 kDa) of the cyanobacterium Nostoc ellipsosporum (Boyd et al. 1997). It binds irreversibly to the surface envelope glycoprotein gp120 by targeting N-linked high-mannose oligosaccharides (Botos et al. 2002; Bewley et al. 2002; Barrientos and Gronenborn 2002) and, in this way, blocks binding of the virus to its receptors on host cells. Recombinant production of CV-N has been attempted in several systems, including bacteria, transgenic plants and transplastomic plants, but protein yields have been relatively low (Colleluori et al. 2005; Sexton et al. 2006; Gao et al. 2010; Elghabi et al. 2011; O’Keefe et al. 2015).
An even more potent small protein with a similar mode of action is the 12.7 kDa lectin griffithsin from the red alga Griffithsia sp. (Mori et al. 2005; Kouokam et al. 2011). While CV-N is active against HIV at low nanomolar concentrations, griffithsin displays anti-viral activity against all isolates of HIV already at picomolar concentrations (Mori et al. 2005; O’Keefe et al. 2009), thus making griffithsin a highly attractive candidate microbicide to prevent sexual transmission of the virus. In addition to its high specific activity against HIV, griffithsin is also extremely resistant to physicochemical degradation and shows high safety (Kouokam et al. 2011). Preclinical development of griffithsin as a potential vaginal microbicide for prevention of HIV transmission is currently underway. Interestingly, griffithsin also displays strong affinity to the envelope glycoproteins of other highly pathogenic viruses, such as the SARS coronavirus (SARS-CoV), hepatitis C virus (HCV) and Ebola virus (O’Keefe et al. 2010; Barton et al. 2014).
Development of griffithsin as an affordable anti-HIV microbicide will require inexpensive mass production of the protein, ideally from a renewable source and not requiring expensive fermentation procedures. Plants represent a particularly cheap, readily scalable and safe production platform for biopharmaceuticals (Ma et al. 2005; Daniell et al. 2009; Rybicki 2010; Marusic et al. 2009; Bock 2014, 2015; Wong-Arce et al. 2017). Therefore, extensive efforts have been made to develop technologies that enable high-level expression of recombinant proteins in plants, including antibodies, antigens for subunit vaccines and microbicides. Expression of griffithsin has been tested in several expression systems, including viral vector-based transient expression in tobacco leaves (O’Keefe et al. 2009; Hahn et al. 2015; Fuqua et al. 2015a, b) and stable transgenic expression in rice seeds (Vamvaka et al. 2016). While transient expression systems often give high expression levels, they incur additional costs due to the need to transfect each new batch of plant material. By contrast, in stable transgenic plants, the starting material for purification can be provided at the (very low) cost of the biomass. Also, stable transgenic plants provide greater batch-to-batch consistency than transiently transfected plant material (Fujiuchi et al. 2016).
Transgene expression from the plastid (chloroplast) genome offers a number of highly attractive features, including precise transgene insertion by homologous recombination, absence of epigenetic gene silencing, and greatly increased transgene confinement due to maternal inheritance of plastids and their efficient exclusion from pollen in most crops (Maliga 2004; Ruf et al. 2007; Bock 2015). The greatest attraction for molecular farming applications lies in the potential of chloroplast-transformed (transplastomic) plants to accumulate extraordinarily high levels of foreign proteins, often one to three orders of magnitude higher than what is possible to achieve by nuclear transgenesis (De Cosa et al. 2001; Tregoning et al. 2003; Molina et al. 2004; Zhou et al. 2008; Oey et al. 2009a, b). However, it is important to note that, while there are numerous cases of spectacularly high expression levels achieved in transplastomic plants, not all foreign proteins accumulate stably in transgenic chloroplasts. Unfortunately, the rules governing protein stability in plastids are only poorly understood (Apel et al. 2010; De Marchis et al. 2012) and, thus, predictions about the success of recombinant protein accumulation in chloroplasts are currently hardly possible. For example, transplastomic expression of CV-N in tobacco was undetectably low, but could be improved by fusion to N-terminal and C-terminal sequences taken from proteins known to be very stable in plastids (Elghabi et al. 2011). Nonetheless, CV-N accumulation levels reached only 0.3% of the total soluble protein (TSP), a value that is two orders of magnitude below the levels attained with PlyGBS, one of the proteins whose N- and C-terminal sequences were used for stabilization of CV-N (Oey et al. 2009a; Elghabi et al. 2011).
Here we have explored the possibility to express griffithsin in tobacco chloroplasts. Although CV-N and griffithsin are similar in size and have a similar mode of antiviral action, their primary sequences are very different. Also, CV-N is a prokaryotic (cyanobacterial) protein, while griffithsin is of eukaryotic (red algal) origin. Thus, the two proteins likely evolved different (in)stability determinants which may have different effects on their stability in the chloroplast (representing a prokaryotic system). Expression of griffithsin from the chloroplast genome was attempted recently (Vafaee et al. 2014), but no accumulation levels were reported and no purification and activity tests were performed. We report here that griffithsin can be expressed to very high levels (of approximately 5% of the plant’s total soluble protein) in tobacco chloroplasts and has similar anti-HIV activity as the recombinant protein produced in bacteria. We also show that, due to its enormous thermal stability, (i) griffithsin can be very easily purified from leaf biomass, (ii) high levels of intact protein can be extracted from dried leaves, and (iii) griffithsin isolated from dry tobacco retains high antiviral activity.
Materials and methods
Plant material and growth conditions
Sterile tobacco (Nicotiana tabacum cv. Petit Havana) plants were grown on agar-solidified MS medium (Murashige and Skoog 1962) containing 30 g/L sucrose. For seed production and generation of material for molecular analyses, plants were transferred to soil and cultivated under standard greenhouse conditions. For inheritance assays, seeds were surface sterilized and sown on agar-solidified MS medium containing 20 g/L sucrose and the appropriate antibiotics for selection (spectinomycin: 500 mg/L, gentamycin: 200 mg/L).
To investigate the recovery of griffithsin from dry tobacco, leaves were harvested from greenhouse-grown plants, dried between tissue paper for approximately 4 months at room temperature, followed by initial tests for the presence of griffithsin and subsequent storage in sealed containers at room temperature until 10 months after harvest, followed by protein purification.
The griffithsin nucleotide sequence (accession number AY744144; Mori et al. 2005) including the sequence for an N-terminal histidine tag was codon-optimized for the tobacco chloroplast genome and chemically synthesized (Epoch Life Science, Missouri City, TX; http://www.epochlifescience.com/). The synthetic grft gene was inserted as NdeI/XbaI fragment into cloning vector pHK20 (Kuroda and Maliga 2001) where it is driven by the plastid rRNA operon promoter fused to the gene10 leader sequence of bacteriophage T7. The griffithsin cassette was subsequently excised as SacI/HindIII fragment and cloned into the similarly cut plasmid pKP9 (Zhou et al. 2008), generating the final transformation vector pGrft1.
Young tobacco leaves were bombarded with vector pGrft1 coated onto gold particles (0.6 µm diameter) using a helium-driven biolistic gun (PDS-1000He; Bio-Rad). Primary transformants were selected on regeneration medium containing 500 mg/L spectinomycin (Svab and Maliga 1993) and subsequently subjected to two additional rounds of regeneration on spectinomycin-containing medium to select against residual copies of the wild-type plastid genome. Spontaneous spectinomycin-resistant lines were eliminated by double selection on medium containing both spectinomycin and streptomycin (500 mg/L each; Svab and Maliga 1993; Bock 2001). Homoplasmic transplastomic plantlets were rooted on hormone-free medium and then transferred to the greenhouse for seed production.
Selectable marker gene removal
For marker elimination, homoplasmic transplastomic plants were crossed to nuclear-transgenic plants expressing a plastid-targeted Cre recombinase (Corneille et al. 2001). The resulting seeds were surface sterilized and cultivated on MS medium containing 20 g/L sucrose and 500 mg/L spectinomycin. White seedlings were transferred to antibiotic-free medium and, after greening and continued growth, transferred to the greenhouse. To also eliminate the nuclear marker gene, plants were pollinated with wild-type pollen. The progeny from these crosses was used for protein purification experiments.
Isolation of nucleic acids and gel blot analyses
Total plant DNA was extracted by a cetyltrimethylammoniumbromide-based method (Doyle and Doyle 1990). Total cellular RNA was isolated with the NucleoSpin RNA Plant kit (Macherey–Nagel). For RFLP analysis, DNA samples (3 µg total DNA) were treated with the restriction enzyme BamHI, followed by separation of the fragments by electrophoresis in 1% agarose gels and blotting onto Hybond XL membranes (GE Healthcare). For northern blot analysis, RNA samples were electrophoretically separated in formaldehyde-containing 1.5% agarose gels and transferred onto Hybond XL membranes.
A restriction fragment covering the entire coding region of the selectable marker gene aadA was purified by agarose gel electrophoresis using the NucleoSpin Extract II kit (Macherey–Nagel) and used as a hybridization probe. Hybridization probes against psaB and grft were generated by PCR using gene-specific primers (PpsaB_for 5′-CCCAGAAAGAGGCTGGCCC-3′ and PpsaB_rev 5′-CCCAAGGGGCGGGAACTGC-3′; Pgrft_for 5′-ATGGGATCTTCTCATCATCATC-3′ and Pgrft_rev 5′-TTAATATTGTTCATAATAAATATCTAAAGA-3′). The resulting amplification products of 550 bp and 420 bp, respectively, were purified and probes were labelled with α[32P]dCTP by random priming (GE Healthcare). Hybridizations were performed at 65 °C in Rapid-Hyb buffer (GE Healthcare) according to the manufacturer’s protocol.
Protein isolation, purification and visualization
Total soluble protein was extracted from leaf samples homogenized in a buffer (buffer 1) containing 50 mM N-2-hydroxyethylpiperazin-N′-2-ethanesulfonic acid (HEPES)-KOH (pH 7.5), 10 mM potassium acetate, 5 mM magnesium acetate, 1 mM EDTA, 1 mM dithiothreitol and 1 mM cOmplete protease inhibitor (Roche). Alternatively, a published extraction buffer (buffer 2: 100 mM Tris, 300 mM NaCl, 20 mM ascorbic acid, 10 mM sodium metabisulfite; Fuqua et al. 2015a, b) was used. Total soluble protein concentrations were determined by the Bradford assay (Roche, Karlsruhe, Germany) using known concentrations of bovine serum albumin (BSA) as a protein standard.
Extraction and purification protocols for griffithsin from tobacco leaves were optimized for yield and purity. Different extraction buffers were tested: (1) the standard native His-tag purification buffers described by QIAGEN (50 mM NaH2PO4, 300 mM NaCl, cOmplete protease inhibitor with or without 1% Triton, including 10 mM imidazole for extraction, 20 mM imidazole for washing and 250 mM imidazole for elution; pH 8 with NaOH), and (2) previously published extraction buffers for griffithsin (Fuqua et al. 2015a, b; 100 mM sodium acetate, 300 mM sodium chloride, 20 mM ascorbic acid, 10 mM sodium metabisulfite, with or without 100 mM MgCl2, pH 4 or 6 with HCl; or 100 mM Tris, 300 mM sodium chloride, 20 mM ascorbic acid, 10 mM sodium metabisulfite, with or without 100 mM MgCl2, pH 8 with HCl). When used for His-tag-based purification, the buffers were modified by inclusion of 10 mM imidazole for extraction. The pH 8 buffer was modified by including 20 mM imidazole for washing and 250 mM imidazole for elution.
For extraction, leaves were frozen in liquid nitrogen, ground and suspended in 200 µL of extraction buffer per 100 mg of material. For dried leaves, 2900 µL buffer were added per 100 mg material. The suspension was kept on ice and vortexed every 5 min, followed by centrifugation at 15,000×g for a total of 15 min at 4 °C. Alternatively, the suspension was incubated under shaking (Eppendorf ThermoMixer comfort) at 700 or 1400 rpm for 15 min at 70 °C followed by centrifugation at 15,000×g for 15 min at 4 °C, 16 °C or 22 °C, or the suspension was centrifuged for 15 min and the supernatant heated for 15 min at 70 °C under shaking at 700 or 1400 rpm, followed by a second centrifugation step of 15 min at 15,000×g at 4 °C. The supernatant from the heat-treated samples was used for His-tag-based protein purification via Ni–NTA Agarose (QIAGEN) following the manufacturer’s protocol. 3 mL of Ni–NTA agarose slurry were used for purification from approximately 8 g of fresh tissue or 1 g of dried tissue (i.e., approximately 25–30 mL of leaf extract). Plant extracts in pH 4 buffer were adjusted to pH 8 with NaOH prior to mixing with Ni–NTA agarose. The Ni–NTA agarose was incubated with the leaf extract for 1 h (rotating at 4 °C) and subsequently loaded onto QIAGEN Polypropylene Columns (5 mL). The eluate from the purification was concentrated and dialyzed into PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, pH 7.4) by ultrafiltration with Amicon ® Ultra-4 centrifugal filters (Merck) with a 3000 NMWL cut-off, reducing the sample to approximately one-tenth of the original volume. The concentration of ultrafiltrated griffithsin samples was determined with the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) using a dilution standard of BSA and recombinant 6xHis-tagged griffithsin (purified from E. coli; NIH AIDS Research & Reference Reagent Program, Germantown, MD) as reference proteins.
To visualize accumulation, extraction efficiency and purity, protein extracts were electrophoretically separated in 10% Tris-Tricine/SDS polyacrylamide gels (Schägger and von Jagow 1987), and either directly visualized by Coomassie blue staining or silver staining, or transferred to Hybond-P PVDF membranes (GE Healthcare) with transfer buffer (192 mM glycine, 25 mM Tris, pH 8.3) in a Trans-Blot cell (Bio-Rad) for 2 h at 1 A. Blots were blocked with 3% BSA and immunodetection was performed with a griffithsin-specific antibody (NIH AIDS Research & Reference Reagent Program) and goat anti-rabbit IgG antibody peroxidase conjugate (Agrisera) as secondary antibody. Detection was performed with an enhanced chemiluminescence system (ECL® PLUS; GE Healthcare). Recombinant histidine-tagged griffithsin from E. coli was used as reference.
Determination of anti-HIV activity of purified griffithsin
HIV-1 BaL neutralization assays were performed according to published procedures (Wei et al. 2003; Montefiori 2005). 200 TCID50 (median tissue culture infective dose) of HIV-1 BaL were incubated with dilutions of purified griffithsin produced in tobacco or E. coli for 1 h at 37 °C in a total volume of 100 µL. Tobacco- and E. coli-produced griffithsin were titrated fivefold seven times in triplicate starting at 2 µg/mL. All dilutions were performed in growth medium (DMEM) supplemented with 10% foetal calf serum (FCS), penicillin–streptomycin (100 units/mL and 100 µg/mL, respectively) and 2 mM L-glutamine. The mixture was then added to 100 µL of TZM-bl cells expressing CD4, CCR5 and the firefly luciferase gene under the control of the HIV long-terminal repeat sequence and grown in medium pre-seeded at a concentration of 1 × 105 cells/mL. A positive control (cells plus virus) and a cell-only background control were also included. After a 24 h incubation at 37 °C in 5% CO2 followed by addition and incubation with lysis buffer, the cell lysate was removed and mixed in a 1:1 ratio with Bright Glo reagent (Promega) in a 96-well black solid plate for luminescence measurements. The percentage reduction in relative light units (RLU) was calculated relative to the RLU of the positive control (cells plus virus). The resulting curve was plotted and analyzed in GraphPad Prism (https://www.graphpad.com/).
Stable transformation of the tobacco plastid genome with a griffithsin expression cassette
To test whether the anti-HIV protein griffithsin can be expressed from the chloroplast genome to high levels, the sequence of the griffithsin gene (grft) was codon optimized by adjusting it to the preferred codon usage in the tobacco plastid DNA (Shimada and Sugiura 1991). To facilitate protein purification, an N-terminal histidine tag (His6) was added to the coding region (NCBI accession number AY744144.1). The synthetic gene construct was inserted into an expression cassette consisting of the ribosomal RNA operon promoter (Prrn) fused to the strong translation initiation signals derived from the gene10 leader of coliphage T7 (Kuroda and Maliga 2001; see Materials and Methods). The griffithsin cassette was then integrated into a standard plastid transformation vector (Zhou et al. 2008) containing a chimeric spectinomycin resistance gene (aadA) as selectable marker. In this vector, the aadA gene is flanked by loxP sites to facilitate post-transformation removal of the antibiotic resistance marker (Fig. 1a; Corneille et al. 2001).
Biolistic plastid transformation experiments in tobacco were followed by selection for resistance to spectinomycin (Svab and Maliga 1993). Primary spectinomycin-resistant clones (Nt-grft lines) were subjected to additional rounds of selection and regeneration to dilute out residual wild-type copies of the highly polyploid plastid genome and isolate homoplasmic transplastomic tissue. Successful transformation and correct targeting of the grft and aadA transgenes to the intergenic spacer separating the trnfM and trnG genes by homologous recombination was analyzed by restriction fragment length polymorphism (RFLP) analysis using Southern blotting (Fig. 1a, b). The results showed the expected hybridization patterns in RFLP analyses with either a probe derived from a neighboring gene in the plastid genome or a probe recognizing the aadA marker gene (Fig. 1b). Absence of a hybridization signal for the wild type-specific fragment preliminarily suggested that the lines were homoplasmic. However, strong exposure of the blots revealed faint hybridization signals corresponding to the expected size of the wild-type plastid DNA fragment (Fig. 1b, and data not shown). Previous work had established that these weak signals come from so-called promiscuous DNA (plastid-derived DNA sequences that are present in the nuclear genome; Hager et al. 1999; Ruf et al. 2000).
To ultimately confirm homoplasmy of the Nt-grft lines, we conducted large-scale inheritance tests by germinating T1 seeds on spectinomycin-containing medium (Bock 2001). No appearance of antibiotic-sensitive seedlings was observed in any of the analyzed lines (Fig. 1c, and data not shown), indicating that the transplastomic Nt-grft lines are homoplasmic.
Selectable marker gene removal from transplastomic plants
To increase the public acceptance of the use of transgenic plants in biotechnology, the post-transformation removal of antibiotic resistance markers is highly desirable. Excision of the aadA cassette is also useful to prevent rearrangements or deletions in the transformed genome due to unwanted homologous recombination between the expression elements controlling the aadA cassette (promoter, 5′ UTR and 3′UTR sequences) and the resident copies of these expression elements in the plastid genome (Rogalski et al. 2006).
Use of a loxP-flanked (‘floxed’) version of the aadA marker gene in our transformation construct (Fig. 1a) allowed excision of the aadA cassette by site-specific recombination triggered by a nucleus-encoded Cre recombinase that is post-translationally imported into plastids (Corneille et al. 2001). To this end, we crossed homoplasmic transplastomic Nt-grft lines (maternal parent) to a nuclear transgenic Cre-expressing line (pollen donor). The progeny was raised on spectinomycin-containing medium to identify seedlings whose plastid genome was devoid of the aadA gene due to Cre-mediated excision from all copies of the plastid genome. These seedlings were easily recognizable by their spectinomycin-sensitive (pale) phenotype. As expected, the progeny segregated into homogeneously pale (complete aadA excision), variegated (incomplete aadA excision) and green (no or low-level aadA excision) seedlings (Fig. 1c). Homogeneously pale seedlings were rescued by transfer to antibiotic-free medium, after recovery grown to maturity in the greenhouse and then crossed to the wild type (as pollen donor) to eliminate the Cre transgene and the linked nuclear antibiotic resistance marker (a gentamycin resistance gene; Corneille et al. 2001) in the next generation. The resulting completely marker-free transplastomic plants (Nt-grft-mf) have no nuclear transgene anymore, lack the aadA marker in the plastid genome and contain grft as the sole transgene (Figs. 1c, 2).
RFLP analyses by Southern blotting and inheritance assays ultimately confirmed that the aadA gene had been completely excised from all copies of the transgenic plastid genome (Fig. 1b, c).
Neither the Nt-grft lines nor the derived marker-free Nt-grft-mf lines displayed any obvious phenotypic abnormalities. Upon transfer to soil and growth under standard greenhouse conditions, all transplastomic plants were indistinguishable from wild-type plants (Fig. 2), with the exception of a slightly delayed initial development (Fig. S1a). However, this was a very subtle phenotype that became less obvious with time and had largely disappeared after a few weeks of growth (Fig. 2).
Griffithsin mRNA and protein accumulation in transplastomic plants
To test for expression of the introduced grft transgene, we first performed northern blot experiments using transgene-specific probes. Hybridization to a grft probe detected a band of the expected size of the mature (monocistronic) grft mRNA (0.58 kb; Fig. 3a) and two larger transcript species that likely result from read-through transcription and termination or processing at the loxP site downstream of the grft gene, as observed previously with transgenes expressed from the same insertion site in the plastid genome (e.g., Zhou et al. 2008). The Nt-grft-mf lines lack a prominent band for the largest transcript species seen in the Nt-grft plants, tentatively suggesting that this RNA species originates from termination or processing within the aadA cassette downstream of the grft gene (Figs. 1a, 3a). As expected, the Nt-grft-mf lines lack aadA transcripts (Fig. 3a, bottom panel), confirming complete marker gene removal from all copies of the plastid genome.
Having confirmed stable grft mRNA accumulation, we next wanted to determine accumulation of the griffithsin protein in chloroplasts. To this end, we conducted a series of western blot analyses using anti-griffithsin antibodies and purified His-tagged griffithsin protein recombinantly expressed in E. coli as a standard for protein quantification (Fig. 3b–e). Since foreign protein accumulation in transplastomic plants can be strongly dependent on leaf age (e.g., Zhou et al. 2008; Oey et al. 2009a, b), we also analyzed a developmental series of leaves of different ages harvested from young or mature transplastomic plants (Fig. 3b).
Western blot analysis revealed a strong signal for the recombinant His-tagged griffithsin protein at the expected size of ~ 14.5 kDa in all transplastomic plants (Fig. 3c). Comparison of Nt-grft with Nt-grft-mf lines revealed no significant differences, indicating that marker excision does not impact recombinant protein accumulation (Fig. 3c). Analysis of Nt-grft leaves of different ages and developmental stages also did not show pronounced differences in griffithsin accumulation levels (Fig. 3d). This finding was further confirmed by Coomassie staining of protein extracts from Nt-grft-mf lines which revealed a strong band for griffithsin in leaves of all ages and developmental stages, with the exception of the very young leaflets (close to the apical meristem) that accumulated substantially lower levels of griffithsin protein (Fig. S1).
Quantification of griffithsin accumulation using two different buffers for extraction of total soluble protein (TSP) yielded slightly different values, presumably because one of the buffers (buffer 1) was less efficient in extraction of griffithsin from leaf material, as also suggested by incomplete denaturation of the griffithsin dimers into monomers (Fig. 3e). Following extraction with the more effective buffer 2, griffithsin was detected at approximately 5% of TSP (Fig. 3e), which represents an extraordinarily high accumulation level, given the small size of the protein.
Purification of griffithsin from transplastomic tobacco plants
Having achieved high levels of griffithsin accumulation in transplastomic plants, we next attempted purification of the protein to (i) be able to determine its biological activity as antiviral agent, and (ii) test if transplastomic plants provide a suitable production platform for the large-scale synthesis and isolation of pure griffithsin as biopharmaceutical. Due to its physicochemical properties and, in particular, its exceptionally high thermal stability, griffithsin can be enriched by heating total protein extracts which results in the denaturation and precipitation of most other cellular proteins (Fuqua et al. 2015a, b).
If strong enrichment by heat treatment of crude protein extracts of transplastomic plants can be achieved, the high levels of griffithsin accumulating in our transplastomic tobacco plants should result in the protein becoming readily detectable in Coomassie-stained polyacrylamide (PAA) gels. Indeed, heating of leaf protein extracts to 70 °C resulted in loss of nearly all abundant cellular proteins and retention of a single prominent band that corresponds in size to griffithsin (Fig. 4a). Testing of a number of different extraction buffers revealed that buffer composition also had an impact on the efficiency of pre-purification and the abundance and pattern of residual contaminants (Fig. 4a).
We then attempted purification taking advantage of the His-tag that had been included in the griffithsin expression construct. Based on the strong enrichment that had been obtained by sample heating (Fig. 4a), further purification to apparent homogeneity by nickel affinity purification was readily achieved (Fig. 4b), providing suitable material for activity tests and yielding approximately 360 µg pure griffithsin per gram fresh weight.
Anti-HIV activity of chloroplast-expressed griffithsin
To determine whether griffithsin extracted from transplastomic tobacco plants is biologically active and can prevent entry of HIV-1 into human cells, virus neutralization tests were performed (Wei et al. 2003; Montefiori 2005). To this end, cultured HeLa cells containing a HIV-inducible luciferase gene were incubated with viral particles in the presence of different concentrations of griffithsin purified from tobacco leaves. These assays revealed efficient virus neutralization by the chloroplast-produced griffithsin that was very similar to the activity of recombinant griffithsin purified from E. coli (Fig. 5a). These data indicate that transplastomic expression of griffithsin results in large amounts of protein that is fully active and displays high antiviral activity.
Purification of active griffithsin from dried tobacco
To facilitate rapid scale-up of the production of plant-based biopharmaceuticals, it is desirable to be able to store the raw material (plant biomass) for a longer period of time. This removes the need to respond to increasing demands by producing large amounts of plant biomass, which represents the most time-consuming step in the production process. The long-term storage procedure used in the tobacco industry relies on drying of the harvested leafy biomass. We, therefore, wanted to test whether chloroplast-synthesized griffithsin would remain stable upon drying and during storage, and retain its biological activity. We, therefore, dried leaves harvested from transplastomic griffithsin-producing plants and stored them at room temperature for up to 10 months after harvest. Afterwards, proteins were extracted and purification of griffithsin was attempted. Immunoblot analysis of total soluble protein extracts revealed high recovery of full-length griffithsin from dried tobacco and no evidence of appreciable protein degradation during drying or long-term storage (Fig. 6a).
Purification of griffithsin from dried tobacco was slightly less efficient than protein purification from fresh or frozen leaf material (Fig. 6b). Importantly, griffithsin purified from dried tobacco retained high anti-HIV activity in virus neutralization assays (Fig. 5b, c), demonstrating that dried leaf biomass facilitates long-term storage and provides suitable source material for extraction of griffithsin upon demand.
In the course of this work, we have investigated the possibility to produce the potent anti-HIV protein griffithsin in tobacco chloroplasts. Previous attempts to synthesize cyanovirin-N, a longer known but less potent anti-HIV protein, in trangenic chloroplasts had met with limited success (Elghabi et al. 2011). Cyanovirin-N turned out to be rather unstable in chloroplasts and, although protein accumulation could be improved by fusion to N- and/or C-terminal sequences taken from highly stable proteins, accumulation levels remained relatively low (Elghabi et al. 2011). By contrast, griffithsin, a protein of similar size but unrelated in primary amino acid sequence, accumulated in transplastomic tobacco plants to levels of up to 5% of TSP (Fig. 3). Considering the small size of the recombinant protein (of only 14.5 kDa), this is an exceptionally high expression level that suggests that, unlike cyanovirin-N, griffithsin is highly stable in transgenic chloroplasts. It is important to note that the same expression elements were used for the transplastomic expression of cyanovirin-N and griffithsin, suggesting that the strong difference in protein accumulation is due to differences in protein stability. Why griffithsin is so much more stable than cyanovirin-N is currently unclear. Although some determinants of chloroplast protein (in)stability have recently been uncovered (Apel et al. 2010; De Marchis et al. 2012; Rowland et al. 2015), we are still far from being able to explain why certain proteins are less stable than others (let alone to predict the stability of foreign proteins to be expressed in plastids).
Chloroplast-produced griffithsin could be easily purified to apparent homogeneity. The purified protein displayed high HIV-neutralizing activity and showed no evidence of cytotoxicity in bioassays with HeLa cells (Fig. 5), suggesting that transplastomic plants can provide a cost-effective and easily scalable production platform for this important antiviral agent. In the absence of an AIDS vaccine, microbicides that prevent new viral infections are likely to become an important part of future anti-HIV strategies (and perhaps, also of strategies to control other viruses that griffithsin binds to; O’Keefe et al. 2010; Barton et al. 2014).
In this work, we also explored the possibility to use dry tobacco as storable material for recombinant protein purification on demand. Interestingly, griffithsin remained stable during drying and long-term storage and retained high antiviral activity (Figs. 5, 6). The IC50 value of griffithsin extracted from dry tobacco is slightly higher than that of griffithsin purified from fresh biomass or from E. coli (Fig. 5c). The reason for this difference is currently unknown and could be related to some activity loss upon drying and/or storage or, alternatively, lower purity of the protein samples due to the different starting material and/or differences in sample preparation (leading to an overestimation of the griffithsin concentration and thus giving lower apparent activity). Nonetheless, similar to rice grains (Vamvaka et al. 2016), dried tobacco leaves provide an attractive option for long-term storage of large amounts of raw material for griffithsin extraction upon demand. This is of particular importance to the potential use of griffithsin in the developing world, where the demand for anti-HIV microbicides is greatest. Although griffithsin can be expressed also to high levels by transient transformation of fresh biomass (O’Keefe et al. 2009), the procedures involved are too complicated and demanding to be implemented locally.
In summary, our work reported here demonstrates the feasibility of using transplastomic plants as highly efficient and cost-effective production platform for griffithsin, the currently most promising anti-HIV agent. Moreover, we have shown that dried tobacco can serve as source material for purification of griffithsin, thus enabling quick scale-up of production and rapid response to increasing demands.
Andrabi R, Bhiman JN, Burton DR (2018) Strategies for a multi-stage neutralizing antibody-based HIV vaccine. Curr Op Immunol 53:143–151
Apel W, Schulze WX, Bock R (2010) Identification of protein stability determinants in chloroplasts. Plant J 63:636–650
Barrientos LG, Gronenborn AM (2002) The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution. Biochem Biophys Res Commun 298:598–602
Barton C, Kouokam JC, Lasnik AB, Foreman O, Cambon A, Brock G, Montefiori DC, Vojdani F, McCormick AA, O’Keefe BR, Palmer KE (2014) Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Antimicrob Agents Chemother 58:120–127
Bewley CA, Kiyonaka S, Hamachi I (2002) Site-specific discrimination by cyanovirin-N for α-linked trisaccharides comprising the three arms of Man8 and Man9. J Mol Biol 322:881–889
Bock R (2001) Transgenic plastids in basic research and plant biotechnology. J Mol Biol 312:425–438
Bock R (2014) Genetic engineering of the chloroplast: novel tools and new applications. Curr Opin Biotechnol 26:7–13
Bock R (2015) Engineering plastid genomes: Methods, tools, and applications in basic research and biotechnology. Annu Rev Plant Biol 66:211–241
Botos I, O´Keefe BR, Shenoy SR, Cartner LK, Ratner DM, Seeberger PH, Boyd MR, Wlodawer A (2002) Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J Biol Chem 277:34336–34342
Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O´Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina IIJH, Buckheit RW Jr, Nara PL, Pannell LK, Sowder RC, Henderson LE (1997) Discovery of Cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother 41:1521–1530
Colleluori DM, Tien D, Kang F, Pagliei T, Kuss R, McCormick T, Watson K, McFadden K, Chaiken I, Buckheit RW Jr, Romano J (2005) Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development. Protein Expr Purif 39:229–236
Corneille S, Lutz K, Svab Z, Maliga P (2001) Efficient elimination of selectable marker genes from the plastid genome by the CRE-lox-site-specific recombination system. Plant J 27:171–178
Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14:669–679
De Cosa B, Moar W, Lee S-B, Miller M, Daniell H (2001) Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol 19:71–74
De Marchis F, Pompa A, Bellucci M (2012) Plastid proteostasis and heterologous protein accumulation in transplastomic plants. Plant Physiol 160:571–581
Doyle JJ, Doyle JL (1990) Isolation of plant DNA from fresh tissue. Focus 12:13–15
Elghabi Z, Karcher D, Zhou F, Ruf S, Bock R (2011) Optimization of the expression of the HIV fusion inhibitor cyanovirin-N from the tobacco plastid genome. Plant Biotechnol J 9:599–608
Fujiuchi N, Matoba N, Matsuda R (2016) Environment control to improve recombinant protein yields in plants based on Agrobacterium-mediated transient gene expression. Front Bioeng Biotechnol 4:23
Fuqua JL, Wanga V, Palmer KE (2015a) Improving the large scale purification of the HIV microbicide, griffithsin. BMC Biotechnol 15:12
Fuqua JL, Hamorsky K, Khalsa G, Matoba N, Palmer KE (2015b) Bulk production of the antiviral lectin griffithsin. Plant Biotechnol J 13:1160–1168
Gao X, Chen W, Guo C, Qian C, Liu G, Ge F, Huang Y, Kitazato K, Wang Y, Xiong S (2010) Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion. Appl Microbiol Biotechnol 85:1051–1060
Haase AT (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464:217–223
Hager M, Biehler K, Illerhaus J, Ruf S, Bock R (1999) Targeted inactivation of the smallest plastid genome-encoded open reading frame reveals a novel and essential subunit of the cytochrome b6f complex. EMBO J 18:5834–5842
Hahn S, Giritch A, Bartels D, Bortesi L, Gleba Y (2015) A novel and fully scalable Agrobacterium spray-based process for manufacturing cellulases and other cost-sensitive proteins in plants. Plant Biotechnol J 13:708–716
Kouokam JC, Huskens D, Schols D, Johannemann A, Riedell SK, Walter W, Walker JM, Matoba N, O’Keefe BR, Palmer KE (2011) Investigation of Griffithsin’s interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. PLoS ONE 6:e22635
Kuroda H, Maliga P (2001) Complementarity of the 16S rRNA penultimate stem with sequences downstream of the AUG destabilizes the plastid mRNAs. Nucleic Acids Res 29:970–975
Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M Jr, Lifson JD, Salkowitz JR, Rodriquez B, Blauvelt A, Hartley O (2004) Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306:485–487
Levine AJ (2008) Why do we not yet have a human immunodeficiency virus vaccine? J Virol 82:11998–12000
Ma JK-C, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM (2005) Molecular farming for new drugs and vaccines. EMBO Rep 6:593–599
Maliga P (2004) Plastid transformation in higher plants. Annu Rev Plant Biol 55:289–313
Marusic C, Vitale A, Pedrazzini E, Donini M, Frigerio L, Bock R, Dix PJ, McCabe MS, Bellucci M, Benvenuto E (2009) Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study. Transgenic Res 18:499–512
Molina A, Hervás-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi J (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol J 2:141–153
Montefiori DC (2005) Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol 12:1–17
Mori T, O’Keefe BR, Sowder IIRC., Bringans S, Gardella R, Berg S, Cochran P, Turpin JA, Buckheit RW Jr, McMahon JB, Boyd MR (2005) Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem 280:9345–9353
Murashige T, Skoog F (1962) A revised medium for rapid growth and bio assays with tobacco tissue culture. Physiol Plant 15:473–497
O’Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, Mirsalis J, d’Andrea A-L, Hume SD, Bratcher B, Saucedo CJ, McMahon JB, Pogue GP, Palmer KE (2009) Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci USA 106:6099–6104
O’Keefe BR, Giomarelli B, Barnard DL, Shenoy SR, Chan PK, McMahon JB, Palmer KE, Barnett BW, Meyerholz DK, Wohlford-Lenane CL, McCray PB Jr (2010) Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol 84:2511–2521
O’Keefe BR, Murad AM, Vianna GR, Ramessar K, Saucedo CJ, Wilson J, Buckheit KW, da Cunha NB, Araújo ACG, Lacorte CC, Madeira L, McMahon JB, Rech EL (2015) Engineering soya bean seeds as a scalable platform to produce cyanovirin-N, a non-ARV microbicide against HIV. Plant Biotechnol J 13:884–892
Oey M, Lohse M, Kreikemeyer B, Bock R (2009a) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 57:436–445
Oey M, Lohse M, Scharff LB, Kreikemeyer B, Bock R (2009b) Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc Natl Acad Sci USA 106:6579–6584
Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, Fekete RA, Kar S, Adhya S, Hamer DH (2005) Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci USA 102:11993–11998
Rogalski M, Ruf S, Bock R (2006) Tobacco plastid ribosomal protein S18 is essential for cell survival. Nucleic Acids Res 34:4537–4545
Rowland E, Kim J, Bhuiyan NH, van Wijk KJ (2015) The Arabidopsis chloroplast stromal N-terminome: complexities of amino-terminal protein maturation and stability. Plant Physiol 169:1881–1896
Ruf S, Biehler K, Bock R (2000) A small chloroplast-encoded protein as a novel architectural component of the light-harvesting antenna. J Cell Biol 149:369–377
Ruf S, Karcher D, Bock R (2007) Determining the transgene containment level provided by chloroplast transformation. Proc Natl Acad Sci USA 104:6998–7002
Rybicki EP (2010) Plant-made vaccines for humans and animals. Plant Biotechnol J 8:620–637
Schägger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379
Sexton A, Drake PM, Mahmood N, Harman SJ, Shattock RJ, Ma JK-C (2006) Transgenic plant production of Cyanovirin-N, an HIV microbicide. FASEB J 20:356–358
Shimada H, Sugiura M (1991) Fine structural features of the chloroplast genome: comparison of the sequenced chloroplast genomes. Nucleic Acids Res 19:983–995
Svab Z, Maliga P (1993) High-frequency plastid transformation in tobacco by selection for a chimeric aadA gene. Proc Natl Acad Sci USA 90:913–917
Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, Bowe F, Fairweather N, Ytterberg J, van Wijk KJ, Dougan G, Maliga P (2003) Expression of tetanus toxin fragment C in tobacco chloroplasts. Nucleic Acids Res 31:1174–1179
Vafaee Y, Staniek A, Mancheno-Solano M, Warzecha H (2014) A modular cloning toolbox for the generation of chloroplast transformation vectors. PLoS ONE 9:e110222
Vamvaka E, Arcalis E, Ramessar K, Evans A, O’Keefe BR, Shattock RJ, Medina V, Stöger E, Christou P, Capell T (2016) Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV. Plant Biotechnol J 14:1427–1437
Vanpouille C, Arakelyan A, Margolis L (2012) Microbicides: still a long road to success. Trends Microbiol 20:369–375
Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ, Springer MS, Moore JP (2005) Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438:99–102
Virgin HW, Walker BD (2010) Immunology and the elusive AIDS vaccine. Nature 464:224–231
Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM (2003) Antibody neutralization and escape by HIV-1. Nature 422:307–312
Wong-Arce A, González-Ortega O, Rosales-Mendoza S (2017) Plant-made vaccines in the fight against cancer. Trends Biotechnol 35:241–256
Zhou F, Badillo-Corona JA, Karcher D, Gonzalez-Rabade N, Piepenburg K, Borchers A-MI, Maloney AP, Kavanagh TA, Gray JC, Bock R (2008) High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 6:897–913
Open access funding provided by Max Planck Society. We thank Claudia Hasse, Pierre Endries and Dr. Stephanie Ruf for help with plant transformation. This research was supported by the Max Planck Society (Max-Planck-Gesellschaft) and a grant from the European Union (Horizon 2020 Framework Programme, Newcotiana, 760331-2) to RB and JKCM.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Hoelscher, M., Tiller, N., Teh, A.YH. et al. High-level expression of the HIV entry inhibitor griffithsin from the plastid genome and retention of biological activity in dried tobacco leaves. Plant Mol Biol 97, 357–370 (2018). https://doi.org/10.1007/s11103-018-0744-7
- Plastid transformation
- Nicotiana tabacum
- Molecular farming
- Antiviral agent